An aesthetics nurse from County Down gave prescriptions to clients using the details of other clients, a court has heard.

Exclusive: ASA calls number of parallel probes ‘significant’ and describes tackling issue as ‘priority’ after it issued ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

Outside the game, commercials are a big part of Super Bowl Sunday. Companies pay large amounts of money for their ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...

A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...

Experts have sounded the alarm about blockbuster weight loss drugs like Ozempic leaving users blind. Several studies have linked the shots to conditions that cause inflammation and block blood ...